EVI1 protein interaction dynamics: targetable for therapeutic intervention?

Roberto Paredes, Nora Doleschall, Kathleen Connors, Bethany Geary, Stefan Meyer

Research output: Contribution to journalReview articlepeer-review

52 Downloads (Pure)


High expression of the transcriptional regulator EVI1 encoded at the MECOM locus at 3q26 is one of the most aggressive oncogenic drivers in acute myeloid leukemia (AML) and carries a very poor prognosis. How EVI1 confers leukemic transformation and chemotherapy resistance in AML is subject to important ongoing clinical and experimental studies. Recent discoveries have revealed critical details on genetic mechanisms of the activation of EVI1 overexpression and downstream events of aberrantly high EVI1 expression. Here we review and discuss aspects concerning the protein interactions of EVI1 and the related proteins MDS-EVI1 and ΔEVI1 from the perspective of their potential for therapeutic intervention.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalExperimental Hematology
Early online date24 Dec 2021
Publication statusPublished - 1 Mar 2022

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre


Dive into the research topics of 'EVI1 protein interaction dynamics: targetable for therapeutic intervention?'. Together they form a unique fingerprint.

Cite this